secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001493152-25-005633
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa receives Nasdaq bid-price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified Processa that common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has until August 4, 2025 to regain compliance by closing at $1.00 or more for 10 consecutive days.
- If not compliant by deadline, may qualify for a second 180-day period or face potential delisting.
- Stock continues trading under symbol PCSA on Nasdaq Capital Market during cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225005633/0001493152-25-005633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225005633/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer